Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy

被引:21
作者
Gomes, Paulo J. [1 ]
Ousler, George W. [1 ]
Welch, Donna L. [1 ]
Smith, Lisa M. [1 ]
Coderre, Jeffrey [1 ]
Abelson, Mark B. [1 ,2 ]
机构
[1] Ora Inc, 300 Brickstone Sq, Andover, MA 01810 USA
[2] Harvard Med Sch, Schepens Eye Res Inst, Boston, MA USA
来源
CLINICAL OPHTHALMOLOGY | 2013年 / 7卷
关键词
allergic conjunctivitis; dry eye; conjunctival allergen challenge; controlled adverse environment; comorbidity;
D O I
10.2147/OPTH.S38732
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: The goal of this study was to assess the effect of a controlled adverse environment (CAE) challenge on subjects with both allergic conjunctivitis and dry eye. Methods: Thirty-three subjects were screened and 17 completed this institutional review board-approved study. Subjects underwent baseline ocular assessments and conjunctival allergen challenge (CAC) on days 0 and 3. Those who met the ocular redness and itching criteria were randomized to receive either the controlled adverse environment (CAE) challenge ( group A, n = 9) or no challenge (group B, n = 8) at day 6. Thirty minutes after CAE/no-CAE, subjects were challenged with allergen and their signs and symptoms graded. Exploratory confocal microscopy was carried out in a subset of subjects at hourly intervals for 5 hours post-CAC on days 3 and 6. Results: Seven minutes post-CAC, subjects exposed to the CAE had significantly greater itching (difference between groups, 0.55 +/- 0.25, P = 0.028), conjunctival redness (0.59 +/- 0.19, P = 0.002), episcleral redness ( 0.56 +/- 0.19, P = 0.003) and mean overall redness (mean of conjunctival, episcleral, and ciliary redness, 0.59 +/- 0.14, P < 0.001). The mean score at 7, 15, and 20 minutes post-CAC for conjunctival redness (0.43 +/- 0.17, P = 0.012), episcleral redness (0.49 +/- 0.15, P = 0.001), mean overall redness in all regions (0.43 +/- 0.15, P = 0.005), and mean chemosis (0.20 +/- 0.08, P = 0.017) were also all significantly greater in CAE-treated subjects. Confocal microscopic images of conjunctival vessels after CAC showed more inflammation in CAE-treated subjects. Conclusion: In subjects with both dry eye and allergic conjunctivitis, exposure to adverse environmental conditions causes an ocular surface perturbation that can intensify allergic reactions.
引用
收藏
页码:157 / 165
页数:9
相关论文
共 7 条
  • [1] Aqueous-Deficient Dry Eye Exacerbates Signs and Symptoms of Allergic Conjunctivitis in Mice
    Kishimoto, Tatsuma
    Ishida, Waka
    Nakajima, Isana
    Fukuda, Ken
    Yamashiro, Kenji
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [2] Thymosin β4 significantly reduces the signs of dryness in a murine controlled adverse environment model of experimental dry eye
    Sosne, Gabriel
    Kim, Chaesik
    Kleinman, Hynda K.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 : S155 - S161
  • [3] TNF-α inhibitor tanfanercept (HBM9036) improves signs and symptoms of dry eye in a phase 2 trial in the controlled adverse environment in China
    Yanling Dong
    Shuang Wang
    Lin Cong
    Ting Zhang
    Jun Cheng
    Nannan Yang
    Xiaohong Qu
    Dongfang Li
    Xueying Zhou
    Holly Wang
    Michael Lee
    Meng Wang
    Stephen Chen
    George W. Ousler
    Xiaoxiang Chen
    Lixin Xie
    International Ophthalmology, 2022, 42 : 2459 - 2472
  • [4] TNF-α inhibitor tanfanercept (HBM9036) improves signs and symptoms of dry eye in a phase 2 trial in the controlled adverse environment in China
    Dong, Yanling
    Wang, Shuang
    Cong, Lin
    Zhang, Ting
    Cheng, Jun
    Yang, Nannan
    Qu, Xiaohong
    Li, Dongfang
    Zhou, Xueying
    Wang, Holly
    Lee, Michael
    Wang, Meng
    Chen, Stephen
    Ousler, George W.
    Chen, Xiaoxiang
    Xie, Lixin
    INTERNATIONAL OPHTHALMOLOGY, 2022, 42 (08) : 2459 - 2472
  • [5] Symptom improvement in dry eye subjects following intranasal tear neurostimulation: Results of two studies utilizing a controlled adverse environment
    Pattar, Guruprasad R.
    Jerkins, Gary
    Evans, David G.
    Torkildsen, Gail L.
    Ousler, George W.
    Hollander, David A.
    Holdbrook, Mark
    Senchyna, Michelle
    OCULAR SURFACE, 2020, 18 (02) : 249 - 257
  • [6] SkQ1 Ophthalmic Solution for Dry Eye Treatment: Results of a Phase 2 Safety and Efficacy Clinical Study in the Environment and During Challenge in the Controlled Adverse Environment Model
    Anton Petrov
    Natalia Perekhvatova
    Maxim Skulachev
    Linda Stein
    George Ousler
    Advances in Therapy, 2016, 33 : 96 - 115
  • [7] SkQ1 Ophthalmic Solution for Dry Eye Treatment: Results of a Phase 2 Safety and Efficacy Clinical Study in the Environment and During Challenge in the Controlled Adverse Environment Model
    Petrov, Anton
    Perekhvatova, Natalia
    Skulachev, Maxim
    Stein, Linda
    Ousler, George
    ADVANCES IN THERAPY, 2016, 33 (01) : 96 - 115